NATIONAL COALITION OF PHARMACEUTICAL DISTRIBUTORS

Lobbying Spend

—

Filings

Firms Hired

Active Period

2006–2010

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2010	—	3	1
2009	—	4	1
2008	—	4	1
2007	—	2	1
2006	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
CONSULTANTS COLLABORATIVE -- MATTHEW R. SIMMONS	—	15

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	14
SENATE	14
Food & Drug Administration (FDA)	7
Small Business Administration (SBA)	5
Drug Enforcement Administration (DEA)	3
Federal Trade Commission (FTC)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	15
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	1

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5839110th Congress

Safeguarding America's Pharmaceuticals Act of 2008

Cited source text and reported amounts

Support for H.R. 5839

Client expense: — · Firm income: $60,000

Matched citations: H.R. 5839

NATIONAL COALITION OF PHARMACEUTICAL DISTRIBUTORS — Lobbying Disclosure | Poliscope